The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries
Objective. Aspirin usage is associated with increased risk of gastrointestinal bleeding. The present study explored the potential of teprenone, an antiulcerative, in preventing aspirin-related gastric mucosal injuries. Methods. 280 patients with coronary diseases, naïve to aspirin medication, were a...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2019/6532876 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558257978212352 |
|---|---|
| author | Jing Zhao Yihong Fan Wu Ye Wen Feng Yue Hu Lijun Cai Bin Lu |
| author_facet | Jing Zhao Yihong Fan Wu Ye Wen Feng Yue Hu Lijun Cai Bin Lu |
| author_sort | Jing Zhao |
| collection | DOAJ |
| description | Objective. Aspirin usage is associated with increased risk of gastrointestinal bleeding. The present study explored the potential of teprenone, an antiulcerative, in preventing aspirin-related gastric mucosal injuries. Methods. 280 patients with coronary diseases, naïve to aspirin medication, were admitted between 2011 and 2013 at the First Affiliated Hospital of Zhejiang Chinese Medical University and randomized into two groups (n=140). The aspirin group received aspirin enteric-coated tablets 100 mg/day, while the aspirin+teprenone group received teprenone 50 mg 3 times/day along with aspirin. The patients were recorded for gastrointestinal symptoms and gastric mucosal injuries during a follow-up period of 12 months with 3-month intervals. Results. During the 3-month follow-up, no significant difference was observed in the incidence rate of gastrointestinal symptoms between the two groups (P=0.498). However, the incidence rate of gastrointestinal symptoms was significantly lower in the aspirin+teprenone group than in the aspirin group during the follow-ups at 6 months (P=0.036) and 12 months (P=0.036). The incidence rate of gastric mucosal injuries in the aspirin group was significantly increased at 12 months compared to that at 3 months (P=0.016). The incidence rates at 12 months and cumulative for the entire follow-up period in the aspirin+teprenone group were both significantly lower than those of the aspirin group (P=0.049 and P=0.001, respectively). Conclusion. Long-term use of low-dose aspirin causes varying degrees of gastric mucosal damages and gastrointestinal symptoms; the severity will increase within a certain range with the extension of medication duration. Teprenone mitigates the gastrointestinal symptoms caused by low-dose aspirin, lowering both the incidence and severity of gastric mucosal injuries and exerting a positive protective effect. |
| format | Article |
| id | doaj-art-87b4cfb1c587441382dc26035ce775f3 |
| institution | Kabale University |
| issn | 1687-6121 1687-630X |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Gastroenterology Research and Practice |
| spelling | doaj-art-87b4cfb1c587441382dc26035ce775f32025-02-03T01:32:51ZengWileyGastroenterology Research and Practice1687-61211687-630X2019-01-01201910.1155/2019/65328766532876The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal InjuriesJing Zhao0Yihong Fan1Wu Ye2Wen Feng3Yue Hu4Lijun Cai5Bin Lu6Department of Gastroenterology, First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, ChinaDepartment of Gastroenterology, First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, ChinaDepartment of Gastroenterology, First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, ChinaDepartment of Gastroenterology, First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, ChinaDepartment of Gastroenterology, First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, ChinaDepartment of Gastroenterology, First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, ChinaDepartment of Gastroenterology, First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, ChinaObjective. Aspirin usage is associated with increased risk of gastrointestinal bleeding. The present study explored the potential of teprenone, an antiulcerative, in preventing aspirin-related gastric mucosal injuries. Methods. 280 patients with coronary diseases, naïve to aspirin medication, were admitted between 2011 and 2013 at the First Affiliated Hospital of Zhejiang Chinese Medical University and randomized into two groups (n=140). The aspirin group received aspirin enteric-coated tablets 100 mg/day, while the aspirin+teprenone group received teprenone 50 mg 3 times/day along with aspirin. The patients were recorded for gastrointestinal symptoms and gastric mucosal injuries during a follow-up period of 12 months with 3-month intervals. Results. During the 3-month follow-up, no significant difference was observed in the incidence rate of gastrointestinal symptoms between the two groups (P=0.498). However, the incidence rate of gastrointestinal symptoms was significantly lower in the aspirin+teprenone group than in the aspirin group during the follow-ups at 6 months (P=0.036) and 12 months (P=0.036). The incidence rate of gastric mucosal injuries in the aspirin group was significantly increased at 12 months compared to that at 3 months (P=0.016). The incidence rates at 12 months and cumulative for the entire follow-up period in the aspirin+teprenone group were both significantly lower than those of the aspirin group (P=0.049 and P=0.001, respectively). Conclusion. Long-term use of low-dose aspirin causes varying degrees of gastric mucosal damages and gastrointestinal symptoms; the severity will increase within a certain range with the extension of medication duration. Teprenone mitigates the gastrointestinal symptoms caused by low-dose aspirin, lowering both the incidence and severity of gastric mucosal injuries and exerting a positive protective effect.http://dx.doi.org/10.1155/2019/6532876 |
| spellingShingle | Jing Zhao Yihong Fan Wu Ye Wen Feng Yue Hu Lijun Cai Bin Lu The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries Gastroenterology Research and Practice |
| title | The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries |
| title_full | The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries |
| title_fullStr | The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries |
| title_full_unstemmed | The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries |
| title_short | The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries |
| title_sort | protective effect of teprenone on aspirin related gastric mucosal injuries |
| url | http://dx.doi.org/10.1155/2019/6532876 |
| work_keys_str_mv | AT jingzhao theprotectiveeffectofteprenoneonaspirinrelatedgastricmucosalinjuries AT yihongfan theprotectiveeffectofteprenoneonaspirinrelatedgastricmucosalinjuries AT wuye theprotectiveeffectofteprenoneonaspirinrelatedgastricmucosalinjuries AT wenfeng theprotectiveeffectofteprenoneonaspirinrelatedgastricmucosalinjuries AT yuehu theprotectiveeffectofteprenoneonaspirinrelatedgastricmucosalinjuries AT lijuncai theprotectiveeffectofteprenoneonaspirinrelatedgastricmucosalinjuries AT binlu theprotectiveeffectofteprenoneonaspirinrelatedgastricmucosalinjuries AT jingzhao protectiveeffectofteprenoneonaspirinrelatedgastricmucosalinjuries AT yihongfan protectiveeffectofteprenoneonaspirinrelatedgastricmucosalinjuries AT wuye protectiveeffectofteprenoneonaspirinrelatedgastricmucosalinjuries AT wenfeng protectiveeffectofteprenoneonaspirinrelatedgastricmucosalinjuries AT yuehu protectiveeffectofteprenoneonaspirinrelatedgastricmucosalinjuries AT lijuncai protectiveeffectofteprenoneonaspirinrelatedgastricmucosalinjuries AT binlu protectiveeffectofteprenoneonaspirinrelatedgastricmucosalinjuries |